-
181
Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – protocol for the ERADICATE study: a phase II randomised controlled...
Published 2025-01-01Subjects: “…Prostate cancer…”
Get full text
Article -
182
Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
183
-
184
-
185
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
Published 2025-01-01Subjects: Get full text
Article -
186
No impairment of quality of life after radiotherapy for prostate cancer
Published 2024-12-01Subjects: “…Prostate cancer…”
Get full text
Article -
187
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Published 2025-01-01Subjects: Get full text
Article -
188
Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
Published 2025-01-01Subjects: Get full text
Article -
189
Application of mean maximum Young’s modulus value as a new parameter for differential diagnosis of prostate diseases
Published 2025-01-01Subjects: Get full text
Article -
190
Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI
Published 2025-06-01Subjects: “…Prostate cancer…”
Get full text
Article -
191
-
192
Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells
Published 2024-12-01Subjects: “…metastatic prostate cancer…”
Get full text
Article -
193
An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer
Published 2025-01-01Subjects: “…metastatic castration-resistant prostate cancer…”
Get full text
Article -
194
Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer
Published 2023-06-01Subjects: Get full text
Article -
195
GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy
Published 2024-12-01Subjects: Get full text
Article -
196
The heat of the battle: inflammation’s role in prostate cancer development and inflammation-targeted therapies
Published 2025-02-01Subjects: “…Prostate cancer…”
Get full text
Article -
197
Current biomarkers of prostate cancer
Published 2021-12-01Subjects: “…prostate cancer…”
Get full text
Article -
198
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-...
Published 2025-02-01Subjects: “…metastatic castration-resistant prostate cancer…”
Get full text
Article -
199
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
Published 2025-02-01Subjects: “…prostate cancer…”
Get full text
Article -
200
Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway
Published 2025-01-01Subjects: “…Prostate cancer (PCa)…”
Get full text
Article